Xtant Medical Holdings, Inc.
XTNT
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defectsā¦ read more
Healthcare
Medical Devices
16 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.43
Price-0.60%
$0.00
1Y
Price
Market Cap
$60.285m
Small
Price/Earnings 3y Avg5y Avg
41.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+10.9%
EBITDA Margin+3.9%
Net Profit Margin+12.6%
Free Cash Flow Margin+10.9%
EBITDA Margin+3.9%
Net Profit Margin+12.6%
Free Cash Flow MarginRevenue
$121.907m
+13.5%
1y CAGR+33.1%
3y CAGR+26.1%
5y CAGREarnings
$1.826m
+110.7%
1y CAGR-791.3%
3y CAGR-612.2%
5y CAGREPS
$0.01
+108.3%
1y CAGR-360.2%
3y CAGR-282.6%
5y CAGRBook Value
$48.599m
$78m
Assets$29.401m
Liabilities$15.436m
DebtDebt to Assets
19.8%
1.4x
Debt to EBITDAFree Cash Flow
$7.769m
+132.3%
1y CAGR+10.7%
3y CAGR-73.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company